Perceptive LIFE Sciences Master FUND Ltd., 10% Owner at Aldeyra Therapeutics, Inc. (ALDX), bought 1,000,170 shares at $4.09 ($3.8M) on 2024-04-03, disclosed to the SEC on 2024-04-03.
Open-market purchase of $3.8M ALDX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.25 | 8,374 | $27K | 0.7% |
| 2 | $3.44 | 186,051 | $640K | 16.7% |
| 3 | $3.44 | 186,051 | $640K | 16.7% |
| 4 | $4.09 | 309,847 | $1.3M | 33.0% |
| 5 | $4.09 | 309,847 | $1.3M | 33.0% |
| Total | $3.84 avg | 1,000,170 |
| $3.8M |
| 100% |
| Filing → |
| ACRV | BUY | 2024-04-15 | $20.0M | — | Filing → |
| ALDX | SELL | 2023-10-18 | $5.0M | — | Filing → |
| ATXS | BUY | 2023-10-18 | $14.0M | — | Filing → |